Baker Brothers Advisors - PRELUDE THERAPEUTICS INC ownership

PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 54 filers reported holding PRELUDE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of PRELUDE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$31,282,616
-31.3%
10,123,8240.0%0.18%
-31.8%
Q2 2023$45,557,208
-21.1%
10,123,8240.0%0.26%
-15.9%
Q1 2023$57,705,797
-5.6%
10,123,8240.0%0.31%
-14.4%
Q4 2022$61,147,897
-8.6%
10,123,8240.0%0.37%
-16.2%
Q3 2022$66,918,000
+26.6%
10,123,8240.0%0.44%
+46.0%
Q2 2022$52,846,000
-24.3%
10,123,8240.0%0.30%
-25.2%
Q1 2022$69,854,000
-44.6%
10,123,8240.0%0.40%
-34.6%
Q4 2021$126,042,000
-60.2%
10,123,8240.0%0.61%
-55.9%
Q3 2021$316,370,000
+9.2%
10,123,8240.0%1.39%
+9.1%
Q2 2021$289,845,000
-33.9%
10,123,8240.0%1.27%
-33.1%
Q1 2021$438,665,000
-39.4%
10,123,824
+0.1%
1.90%
-30.3%
Q4 2020$723,988,000
+137.5%
10,118,6360.0%2.73%
+124.0%
Q3 2020$304,875,00010,118,6361.22%
Other shareholders
PRELUDE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Orbimed Advisors 10,909,256$33,709,6010.72%
Boxer Capital, LLC 2,495,018$7,709,6060.41%
Sio Capital Management, LLC 350,000$1,081,5000.34%
Baker Brothers Advisors 10,123,824$31,282,6160.18%
EcoR1 Capital, LLC 1,157,452$3,576,5270.12%
GSA CAPITAL PARTNERS LLP 70,583$2180.02%
Pale Fire Capital SE 30,781$95,1130.01%
Woodline Partners LP 200,000$618,0000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 143,957$444,8270.00%
EXCHANGE TRADED CONCEPTS, LLC 32,907$101,6830.00%
View complete list of PRELUDE THERAPEUTICS INC shareholders